368 related articles for article (PubMed ID: 18266750)
41. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5.
Ohtake H; Shimohata T; Terajima K; Kimura T; Jo R; Kaseda R; Iizuka O; Takano M; Akaiwa Y; Goto H; Kobayashi H; Sugai T; Muratake T; Hosoki T; Shioiri T; Okamoto K; Onodera O; Tanaka K; Someya T; Nakada T; Tsuji S
Neurology; 2004 May; 62(9):1601-3. PubMed ID: 15136690
[TBL] [Abstract][Full Text] [Related]
42. Hemiconvulsion-hemiplegia syndrome in a patient with severe myoclonic epilepsy in infancy.
Sakakibara T; Nakagawa E; Saito Y; Sakuma H; Komaki H; Sugai K; Sasaki M; Kurahashi H; Hirose S
Epilepsia; 2009 Sep; 50(9):2158-62. PubMed ID: 19563349
[TBL] [Abstract][Full Text] [Related]
43. [Leukoencephalopathy with vanishing white matter: A case report].
San Antonio-Arce V; Martín Fernández-Mayoralas D; Muñoz-Jareño N; Fresneda-Machado C; Sáiz-Ayala A; Campos-Castelló J
Rev Neurol; 2006 Nov 1-15; 43(9):535-40. PubMed ID: 17072809
[TBL] [Abstract][Full Text] [Related]
44. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
45. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.
Van Bogaert P; Azizieh R; Désir J; Aeby A; De Meirleir L; Laes JF; Christiaens F; Abramowicz MJ
Ann Neurol; 2007 Jun; 61(6):579-86. PubMed ID: 17455289
[TBL] [Abstract][Full Text] [Related]
46. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
Dietrich J; Lacagnina M; Gass D; Richfield E; Mayer-Pröschel M; Noble M; Torres C; Pröschel C
Nat Med; 2005 Mar; 11(3):277-83. PubMed ID: 15723074
[TBL] [Abstract][Full Text] [Related]
47. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
[TBL] [Abstract][Full Text] [Related]
48. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
[TBL] [Abstract][Full Text] [Related]
49. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
[TBL] [Abstract][Full Text] [Related]
50. [Fulminant orthochromatic leukodystrophy in an adult].
Dousset V; Tison F; Vital A; Henry P
Rev Neurol (Paris); 1998 Jun; 154(5):415-8. PubMed ID: 9773074
[TBL] [Abstract][Full Text] [Related]
51. Vanishing white matter disease in French-Canadian patients from Quebec.
Robinson MÈ; Rossignol E; Brais B; Rouleau G; Arbour JF; Bernard G
Pediatr Neurol; 2014 Aug; 51(2):225-32. PubMed ID: 25079571
[TBL] [Abstract][Full Text] [Related]
52. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
Alsalem A; Shaheen R; Alkuraya FS
Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
[TBL] [Abstract][Full Text] [Related]
53. Vanishing white matter disease.
van der Knaap MS; Pronk JC; Scheper GC
Lancet Neurol; 2006 May; 5(5):413-23. PubMed ID: 16632312
[TBL] [Abstract][Full Text] [Related]
54. Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
Schiffmann R; Elroy-Stein O
Mol Genet Metab; 2006 May; 88(1):7-15. PubMed ID: 16378743
[TBL] [Abstract][Full Text] [Related]
55. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O
J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143
[TBL] [Abstract][Full Text] [Related]
56. Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations.
Lee HN; Koh SH; Lee KY; Ki CS; Lee YJ
Eur J Neurol; 2009 Mar; 16(3):e42-3. PubMed ID: 19170749
[No Abstract] [Full Text] [Related]
57. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.
Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F
Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052
[TBL] [Abstract][Full Text] [Related]
58. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype.
Visser JE; Bloem BR; van de Warrenburg BP
Mov Disord; 2007 May; 22(7):1024-6. PubMed ID: 17343273
[TBL] [Abstract][Full Text] [Related]
59. Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy.
Dibbens LM; Karakis I; Bayly MA; Costello DJ; Cole AJ; Berkovic SF
Arch Neurol; 2011 Jun; 68(6):812-3. PubMed ID: 21670406
[TBL] [Abstract][Full Text] [Related]
60. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
